Pfizer Income from Discontinued Operations 2010-2024 | PFE
Pfizer income from discontinued operations for the twelve months ending September 30, 2024 was $-22M, a 269.23% decline year-over-year.
- Pfizer annual income from discontinued operations for 2023 was $-0.015B, a 350% decline from 2022.
- Pfizer annual income from discontinued operations for 2022 was $0.006B, a 101.38% decline from 2021.
- Pfizer annual income from discontinued operations for 2021 was $-0.434B, a 117.16% decline from 2020.